Journal Title
Biomolecules

BIOMOLECULES

ISSN / eISSN
2218-273X / 2218-273X
Aims and Scope
Biomolecules (ISSN 2218-273X) is an international, peer-reviewed open access journal focusing on biogenic substances and their biological functions, structures, interactions with other molecules, and their microenvironment as well as biological systems. Biomolecules publishes reviews, regular research papers and short communications.  Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

CiteScore
8.30 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Biochemistry Q1 #94/428
Biochemistry, Genetics and Molecular Biology - Molecular Biology Q2 #114/380
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE Q1
Country/Area of Publication
Switzerland
Publisher
MDPI (Basel, Switzerland)
Year Publication Started
2011
Annual Article Volume
1843
Open Access
YES
Contact
ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Research on biomarkers, a special issue was submitted. The efficiency was very high, with a first review taking 20 days and involving 4 reviewers. One of the reviewers raised many statistical questions, which required additional analysis. The second review took 4 days, with 3 reviewers providing additional comments mainly on language and formatting issues. After revisions were made, the paper was accepted within 2 days and underwent a 2-day proofreading process before being published online on the same day. The status changes in the system were as follows:

Pending review (Aug 26)
Under review (Aug 30)
Pending major revision (Sep 19)
Resubmit 1st round (Oct 4)
Pending minor revision (Oct 8)
Resubmit 2nd round (Oct 10)
Pending editor decision (Oct 10)
Accept (Oct 12)
Proof resubmit (Oct 14)
2022-10-14
The reviewer's comments were sharp, but the overall opinion was leaning towards positive. However, in the end, the paper was rejected by the editor but encouraged for resubmission. After making revisions and conducting additional experiments based on the reviewer's comments, the paper went through two more rounds of review, which were much stricter than my stereotypical impression of MDPI. After resubmission, it took less than a month for the paper to be accepted, so the process was still quite fast.
2022-02-09

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now